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Significance of Arteriolar Thickening in IgA Nephropathy and Clinical
Li Zengyan
The First Affiliated Hospital of Baotou Medical College, Baotou, Inner
Mongolia, China
Objective: This study aimed to analyses the changes of the paraglomerular
arterioles and the correlation between arteriolar thickening with clinical or
pathological features in patients with IgA nephropathy.
Methods: (1) Clinical data collection included age, sex, duration, blood pres-
sure, gross hematuria, cholesterol leels, 24-hour urinary protein quantita-
tive, serum creatinine. (2) Pathology of observation: (i) renal biopsy tissue
conventional paraffin, microscopic observation glomerular, interstitial small
tube, small artery pathological conditions, each section 10, the number of
glomerular experiment.it arteriole cross-sectional number 5 p; (ii) in
selected arteriole glomerular around; (iii) vascular measurement applica-
tions of medical image analysis system single-blind method for calculating
the cavity diameter and blood vessels; (iv) statistical methods, statistical
software SPSS 13.0 data using t-test, counting material c2 test, many factors
influencing factors screening method step backward.
Results: (1) Arteriolar thickening was seen in sections of renal biopsy from
71patients (64.5%), and 49 patients (69%) out of them were normotensive.
(2) The characteristics of arteriolar thickening was vessel smooth muscle hy-
pertrophy and/or hyaline deposit in arteriolar wall, both pathological
changes can cause lumenal narrowing. (3) There was a strong correlation
(T2Z 2.851, PZ 0.0059) between the arteriolar thickening index and tubu-
lointerstitial lesions.
Conclusion: The arteriolar thickening was a common and prominent patho-
logical feature in patients with IgA nephropathy. The arteriolar thickening
index was strongly correlated with tubulointerstitial lesions. It reflects the
disease degree and can be used as an important histological prognostic indi-
cator. It might be involved in the pathogenesis of renal fibrosis and the
development of chronic renal failure.http://dx.doi.org/10.1016/j.hkjn.2015.08.112
0251
Effect of Mycophenolate Mofetil on Expression of MicroRNA-155 in
Patients with IgA Nephropathy
Haofei Hu1,2, Yong Cheng He1,2, Qijun Wan1,2
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Objective: This dissertation would investigate the urinary, serum and intra-
renal expressions of miR-155 of patients with IgAN, and try to elucidate
whether MMF could regulate miR-155 expression in IgAN patients.Methods: 33 patients with biopsy-proven IgAN were designated as IgAN
group. 47 IgAN patients who received MMF treatment for 3 months were
matched with IgAN group as MMF group. 15 healthy volunteers were
recruited as members of healthy control group, while 15 patients with renal
cell carcinoma were recruited as members of control group. Serum and urine
samples from all three groups as well as normal renal tissues from the ne-
phrectomy specimen of control group and renal biopsy tissues from IgAN
group were analyzed through real-time PCR to explore the effect of MMF
on expression of urinary and serum miR-155.
Results: In IgAN group, as compared with control group, the urinary, serum
and intra-renal expressions of miR-155 were increased (P < 0.05). Intra-renal
and serum expressions of miR-155 were positively correlated with protein-
uria (r Z 0.402, P Z 0.028; r Z 0.347, P Z 0.046) and inversely correlated
with evaluated glomerular filtration rate (eGFR) (r Z 0.488, P Z 0.008;
r Z 0.343, P Z 0.048) in IgAN group. Urinary expression of miR-155 was
positively correlated with serum expression of miR-155 (r Z 0.639,
P < 0.001) in IgAN group. The serum level of miR-155 in MMF group was
significantly lower than that of IgAN group (P Z 0.045).
Conclusion: The urinary, serum and intra-renal expressions of miR-155 were
significantly increased in patients with IgAN. Intra-renal and serum miR-155
levels were closely related to the progress and severity of IgAN. MMF could
down-regulate the serum level of miR-155 in IgAN. Serum miR-155 might be
considered as biological marker, reflecting the effect of MMF in the treat-
ment of IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.113
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Relevance Between IFN-g Polymorphism and Proteinuria of IgA
Nephropathy
Niya Jia, Caili Wang
The First Affiliated Hospital of Baotou Medical College, Baotou City, Inner
Mongolia, China
Objective: To study the relevance between IFN-g polymorphism and pro-
teinuria of IgA nephropathy.
Methods: Extract DNA from peripheral blood of 131 IgA nephropathy pa-
tients. The SNP in IFNg+874 gene was determined by special sequence
primer of polymerase chain reaction (PCR-SSP). Discuss the relevance be-
tween IFN-g polymorphism and proteinuria of IgA nephropathy.
Results: (1) The patients with IgA nephropathy have significantily different
24-hour urine protein of onset in different genotypes (p < 0.05): the 24-
hour proteinuria in AA genotype is significantily higher than TT+AT genotype.
(2) The rate of large proteinuria in AA genotype is significantly higher than
TT+AT genotype (p < 0.05). (3) Grouped by large proteinuria and non-large
proteinuria, no significant differences were found in age, sex and blood creat-
inine at the onset between AA genotype and TT+AT genotype (p > 0.05).
Conclusion: The relevance between IFN-g polymorphism and proteinuria of
IgA nephropathy has been found. The proteinuria in AA genotype is signifi-
cantly higher. The T allele may play a protective role in the production of
urine protein. The degree of urinary protein has no relevance with age,
sex and blood creatinine at the onset in different genotypes.
S40 IgA Nephropathyhttp://dx.doi.org/10.1016/j.hkjn.2015.08.114Table 1 Baseline characteristics.
No crescent With crescent P value
Number 90 250270
Rs 2856717 Effect on the Clinical Manifestations and Poor Outcome of
IgA Nephropathy
Wei Wang, Guisen Li, Yurong Zou, Ping Zhang, Li Wang
Sichuan Provincial People’s Hospital, Chengdu, China
Objectives: To replicate the association of 7 single nucleotide polymorphisms
(SNPs; which were identified as strong association with IgAN in a genome-wide
association study) and investigate whether the 7 SNPs influence the clinical
manifestation and prognostic for IgAN patients, a case-control genetic study
from an independent western Han cohort was conducted.
Methods: Genomic DNA was extracted from 521 patients with IgAN and 535
healthy controls, and TaqMan allelic discrimination assay was used to type
SNP polymorphism. Traditional linear logistic regression analyses were
used to detect 7 SNP associations in dominant, recessive and additive ge-
netic models. Bonferroni correction was used to adjust the P-values for mul-
tiple testing. A total of 459 IgAN patients with integrated clinical data were
investigated the relationship between the genotype and phenotype of IgAN.
315 IgAN patients were followed-up. Then, a retrospective cohort study of
315 IgAN patients was conducted to explore the relationship between geno-
type and the progression of renal disease over a mean period of
44.49 19.94 months.
Results: After Bonferroni correction, no significant SNP association was
observed between IgAN patients and controls (Pc > 0.05). For genotype-
phenotype correlation studies, marginally significant association of rs
2856717 T/C recessive model for the T allele was significantly associated
with eGFR (< 60 ml/min) of IgAN patients (P Z 0.008, Pc Z 0.056,
OR Z 1.527). T allele at position of rs9275596 was significantly associated
with macroscopic hematuria of IgAN patients under the dominant and addi-
tive models of inheritance (P < 0.001, Pc Z 0.007, OR Z 2.983) and
(P < 0.001, PcZ 0.007, ORZ 2.17), respectively. Results from Kaplan-Meier
analysis showed that patients carrying the TT+TC genotype for rs2856717
had reduce renal survival rate than patients carrying the CC genotype
(85.1% vs. 92.7%, P Z 0.046).
Conclusion: Rs 2856717 may influence the clinical manifestations and poor
outcome of IgAN. Further studies are required to definition of the mecha-
nistic effects of genetic variants on clinical traits.Age at biopsy 36.92 (14.97) 36.35 0.821
Sex (male, % in same
category)
31 (34%) 16 (64%) 0.008
Baseline creatinine 152.74 (137.40) 183.53 (178.21) 0.163
http://dx.doi.org/10.1016/j.hkjn.2015.08.1150287
Effect of FK506 on IgA Nephropathy Rats with Mesangial Cell
Proliferation
Lin Ting Wei, Zhe Wang, Li Ning Jia, Jin Han, Xiao Tao Ma, Feng Ming Dong,
Rong Guo Fu
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Objective: To investigate the effect of FK506 on IgAN rats with mesangial cell
proliferation and its relationship with TRPC ion channels and calcineurin.
Methods: IgAN model was established using “BSA + CCl4 + LPS” method, in
which rats were treated with 0.5, 1.0 mg/kg FK506 every day by intragastric
administration for 2 weeks. We measured the hematuria, proteinuria and the
renal function through the laboratory testing. HE staining were conducted to
observe the pathological conditions. RT-PCR and Western Blotting were per-
formed for detecting the rat renal cortical TRPC1, TRPC4/5, TRPC3/6/7 and
calcineurin mRNA and protein expressions.
Results: The levels of hematuria, proteinuria, serum BUN and sCr were elevated
in IgANgroupcomparedwithnormalgroup(P< 0.01),whichcouldbeameliorated
by treating with FK506 (P < 0.05), especially in high dose group (P < 0.01). HE
staining showed that the degree of kidney pathological damage was relatively
milder in high dose group in comparison with IgAN group. The mRNA and protein
levels of TRPC1 (P< 0.01), TRPC6 (P< 0.01, P< 0.05), calcineurin (P< 0.05) and
the protein expression of TRPC4/5 (P < 0.01) in IgAN group were also increased
compared with normal group. FK506 significantly down-regulated TRPC subtypes
and calcineurin mRNA and protein levels in IgAN rats (P < 0.05).
Conclusion: FK506 can significantly reduce the degree of hematuria and pro-
teinuria, improve renal function in IgAN rats, inhibit theproliferation ofmesan-
gial cell. The effect of FK506 on inhibiting mesangial cell proliferation may be
associated with the inhibition of the TRPC ion channels and calcineurin.
Funding: This work was supported by NSFC No. 81300581, 81470968,
81400740, 81100530.http://dx.doi.org/10.1016/j.hkjn.2015.08.116
0288
Outcome of IgAN With or Without Crescent FormationdA
Restrospective Kidney Survival Analysis
S. K. Chan, H. L. Lo, Y. W. Ho, C. H. Tam, W. C. A. Tang, C. K. D. Lam,
S. H. S. Wong
United Christian Hospital, Hong Kong
Background: Crescentic IgAN (IgA nephropathy) is known to cause rapid
renal function deterioration, similar to other form of IgAN. However
outcome of IgAN with crescent less than 50% glomeruli in Chinese population
is not well understood. Here we included more than 100 patients with
maximal follow up more than 20 years and examined their kidney survival
with or without crescent formation.
Methods:Current patients under the care of our unitwith diagnosis of IgANwere
examination. Patients without full biopsy report were excluded. Baseline char-
acteristics were compared between the two groups. Cox regression analysis was
usedtocompare thekidneysurvival,afteradjusting thebaselinecharacteristics.
End point was defined as either doubling of serum creatinine or starting of RRT,
whichevercameearlier. Survivalwas censored ifpatientdiedbeforeendpointor
kidney survived beyond the end of the study which was 30 June 2015.
Results:191patientswereexaminedand76wereexcluded.Theirbaselinechar-
acteristics are summarized in Table 1. After adjustment was performed, it was
found that presence of crescent itself did not have significant impact on kidney
survival (Table2). Ithas tobenotedthatwhentheonly1casewithmore than50%
crescent formation and poor kidney survival (time from diagnosis to dialysis less
than 2 months) was included to the group with crescent, the result still showed
no significant difference between the two test groups.(umol/L)
